12/9
04:25 pm
limn
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/3
04:31 pm
limn
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/27
02:50 pm
limn
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Liminatus Pharma (NASDAQ:LIMN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/22
02:11 am
limn
Liminatus Pharma (NASDAQ:LIMN) was downgraded by analysts at
Wall Street
High
Report
Liminatus Pharma (NASDAQ:LIMN) was downgraded by analysts at
Wall Street